Journal of Porphyrins and Phthalocyanines · 2017 · 16 citations · 7 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyDrug DiscoveryMolecular OncologyAntineoplastic Drug ClassesBioconjugation ChemistryConjugation ReactionsPhotodynamic TherapyChemical Structure-activity RelationshipsCytotoxicity AssaysLysine ConjugationNatural Product ConjugatesPhototoxicityPhototoxicity Analysis
Syntheses of three new chlorin e 6 conjugates for PDT of tumors are reported. One of the new compounds 17 is conjugated with lysine at the 13 1 -position, but the others are mono-conjugated 14 or diconjugated 15 with the non-amino acid species ethanolamine. Cellular experiments with the three new compounds and previously synthesized non-amino acid 15 2 -conjugates (7–10), 13 1 -monoconjugates 14, 16, and a 13 1 ,15 2 -diconjugate 12 are reported. In vitro cytotoxicity experiments show that the 13 1 -conjugates are more toxic than the 15 2 -conjugates, and the most toxic derivative (dark- and photo-toxicity) is the 13 1 -ethylenediamine conjugate 11. The most useful PDT photosentitizers appear to be the ethanolamine derivatives, conjugated at the 15 2 - and the 13 1 ,15 2 -positions; these show high phototoxicity but relatively low dark toxicity compared with 11, and also the highest dark/photo cytotoxicity ratios.
7
R. G. Waruna Jinadasa, Xiaoke Hu, M. Graça H. Vicente et al. · Journal of Medicinal Chemistry · 2011 · 64 citations
The Structures of Mono-L-aspartyl Chlorin e6 and Its Related Compounds
Shuichi Gomi, T. NISHIZUKA, Osamu Ushiroda et al. · Heterocycles · 1998 · 29 citations · Full text